Aster DM Healthcare Completes Share Allotment Post Amalgamation, Capital Increases
Aster DM Healthcare has allotted 35,35,51,410 equity shares post-amalgamation. The company's capital increased to ₹871.67 crore. The shares will be listed on BSE and NSE.
The significant increase in equity share capital and the subsequent listing on stock exchanges are material corporate actions. This could impact the company's financial structure, shareholding pattern, and market presence, warranting a medium impact assessment.
The announcement details the completion of a share allotment post-amalgamation, which is a procedural corporate action. While it increases the company's capital, it doesn't inherently represent a positive or negative development on its own without further context on the impact of the amalgamation.
Aster DM Healthcare Limited (formerly Aster DM Quality Care Limited) has announced the allotment of 35,35,51,410 fully paid-up equity shares of face value ₹10 each. This allotment is a result of the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited, approved by the National Company Law Tribunal (NCLT), Hyderabad Bench, on 19 June 2026. The Board of Directors, through a resolution by circulation passed on 13 July 2026, approved this allotment to the eligible equity shareholders of the erstwhile Transferor Company as per the approved share exchange ratio of 977 equity shares of Aster DM Healthcare for every 1,000 equity shares held in the Transferor Company.
Consequent to this allotment, the company's issued, subscribed, and paid-up equity share capital has increased from ₹518.12 crore (51,81,21,029 equity shares of ₹10 each) to ₹871.67 crore (87,16,72,439 equity shares of ₹10 each). These newly allotted equity shares will rank pari passu with the existing equity shares and will be listed on BSE Limited and the National Stock Exchange of India Limited, in compliance with SEBI regulations.
The record date for determining the entitlement of equity shareholders for this allotment was previously informed via a letter dated 25 June 2026.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.